PracticeVideosBlogFlashcardsEspañol
All Practice Exams

100+ Free Pneumologia SBPT Practice Questions

Prepare for the Título de Especialista em Pneumologia e Tisiologia (Sociedade Brasileira de Pneumologia e Tisiologia / AMB) exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
100+ Questions
100% Free

Loading practice questions...

Same family resources

Explore More Brazilian Medical Association Specialty Title Concursos (AMB / Título de Especialista)

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

CBR Prova de Título de Especialista em Radiologia e Diagnóstico por Imagem (Brazil)

Practice Questions

PNO — Prova Nacional de Oftalmologia / Título de Especialista (CBO, Brazil)

Practice Questions

TEA — Título de Especialista em Anestesiologia (SBA, Brazil)

Practice Questions

TEC — Título de Especialista em Cardiologia (SBC, Brazil)

Practice Questions

TECAD — Título de Especialista em Cirurgia do Aparelho Digestivo (CBCD, Brazil)

Practice Questions

TECM — Título de Especialista em Clínica Médica (SBCM, Brazil)

Practice Questions
2026 Statistics

Key Facts: Pneumologia SBPT Exam

80–100 Items

Multiple-choice questions on the official SBPT examination (theoretical and case-based)

Edital SBPT / AMB

4–5 Hours

Total examination duration conducted on a single day

Edital SBPT / AMB

R$ 1.800,00

Registration fee for SBPT/AMB members (R$ 3.600,00 for non-members)

Edital SBPT / AMB

60%

Minimum overall passing score benchmark (6.0 out of 10.0 scale)

Regulamento Oficial SBPT / AMB

RQE Pneumologia

Official Specialist Registration Credential Conferred with CFM

Conselho Federal de Medicina (CFM) / AMB

Annual

Official examination frequency organized by SBPT and AMB

Sociedade Brasileira de Pneumologia e Tisiologia

The SBPT Título de Especialista em Pneumologia e Tisiologia is Brazil's premier board certification in respiratory medicine and phthisiology, granted by SBPT and AMB. It evaluates clinical mastery of SBPT guidelines, Brazilian National Tuberculosis Program (PNCT) protocols, pulmonary function testing, thoracic imaging, and critical respiratory care.

Sample Pneumologia SBPT Practice Questions

Try these sample questions to test your Pneumologia SBPT exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 45-year-old man undergoes spirometry for evaluation of chronic cough. According to the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT) and ATS/ERS guidelines for pulmonary function testing, what are the minimum repeatability criteria required for Forced Vital Capacity (FVC) and Forced Expiratory Volume in 1 second (FEV1) across acceptable maneuvers?
A.The difference between the two largest FVC values and the two largest FEV1 values must both be within 150 mL (or 100 mL if FVC is < 1.0 L).
B.The difference between the two largest FVC values and the two largest FEV1 values must both be within 250 mL regardless of absolute volume.
C.The variation coefficient among all performed maneuvers must not exceed 10% for peak expiratory flow (PEF).
D.The difference between the highest and lowest FEV1 values across all attempts must be less than 5% of predicted normal values.
Explanation: According to SBPT and ATS/ERS technical standards, after obtaining at least three acceptable forced expiratory curves, repeatability is achieved when the difference between the two largest FVC values and the two largest FEV1 values is ≤ 150 mL (or ≤ 100 mL if the FVC is less than 1.0 L). This ensures physiological consistency and technical validity before interpreting ventilatory patterns.
2A 38-year-old woman with recurrent wheezing undergoes pre- and post-bronchodilator spirometry. Her baseline FEV1 is 2.00 L. Following the inhalation of 400 mcg of salbutamol via metered-dose inhaler with a spacer, her FEV1 increases to 2.28 L (an absolute gain of 280 mL and a 14% increase). According to SBPT guidelines, how should this bronchodilator response be classified?
A.Positive significant bronchodilator response, satisfying both the absolute volume (≥ 200 mL) and percentage (≥ 12%) thresholds.
B.Negative bronchodilator response, because a minimum absolute gain of 350 mL is required to confirm airway reversibility.
C.Borderline response, requiring a repeat trial with an anticholinergic agent (ipratropium bromide) before confirming reversibility.
D.Positive response based solely on the percentage increase, as the absolute volume requirement is waived when baseline FEV1 is under 2.5 L.
Explanation: SBPT guidelines define a positive (significant) bronchodilator response in adults as an increase in FEV1 and/or FVC of at least 200 mL AND at least 12% compared to baseline pre-bronchodilator values. The patient achieved a 280 mL and 14% increase in FEV1, thereby meeting both mandatory criteria.
3A 74-year-old asymptomatic non-smoker undergoes spirometry before elective surgery. The pre-bronchodilator FEV1/FVC ratio is 0.68, and the post-bronchodilator FEV1/FVC ratio is 0.68. The Lower Limit of Normal (LLN, 5th percentile) for the FEV1/FVC ratio calculated for his age, sex, and height is 0.65. How should this spirometry result be interpreted regarding the presence of obstructive ventilatory defect?
A.Normal ventilatory pattern without obstruction, because the post-bronchodilator FEV1/FVC ratio is above the Lower Limit of Normal (LLN).
B.Definite obstructive ventilatory defect, because the post-bronchodilator FEV1/FVC ratio is below the fixed cutoff of 0.70.
C.Mixed restrictive and obstructive defect, necessitating immediate whole-body plethysmography.
D.Isolated small airway disease, because fixed cutoffs supersede lower limit of normal calculations in geriatric populations.
Explanation: The SBPT and ATS/ERS guidelines recommend using the Lower Limit of Normal (LLN, z-score < -1.64 or 5th percentile) to define airflow obstruction. The fixed FEV1/FVC < 0.70 cutoff leads to substantial overdiagnosis of obstruction in healthy elderly individuals due to the physiological age-related decline in lung elasticity. Because this patient's ratio (0.68) exceeds his LLN (0.65), spirometry is normal.
4A 52-year-old man with systemic sclerosis undergoes pulmonary function testing. Spirometry shows FEV1 58% of predicted, FVC 54% of predicted, and FEV1/FVC ratio 0.82 (normal). To formally confirm a restrictive ventilatory defect, which measurement on body plethysmography is mandatory?
A.Total Lung Capacity (TLC) below the lower limit of normal (< LLN or < 80% of predicted).
B.Residual Volume (RV) below 65% of predicted with preserved Vital Capacity.
C.Functional Residual Capacity (FRC) below 70% of predicted combined with normal airway resistance.
D.Diffusing capacity of the lung for carbon monoxide (DLCO) below 60% of predicted.
Explanation: A restrictive ventilatory defect can only be definitively established by demonstrating a reduction in Total Lung Capacity (TLC < LLN or < 80% of predicted) via body plethysmography, helium dilution, or nitrogen washout. Spirometry showing a reduced FVC with a normal FEV1/FVC ratio is suggestive of restriction but can also occur in air trapping or submaximal effort.
5A 62-year-old heavy smoker with severe COPD undergoes whole-body plethysmography. The report demonstrates: TLC = 135% of predicted, FVC = 62% of predicted, RV = 210% of predicted, and RV/TLC ratio = 58% (normal upper limit 35%). How are these plethysmographic volume abnormalities correctly categorized?
A.Pulmonary hyperinflation combined with severe air trapping.
B.Isolated air trapping without pulmonary hyperinflation.
C.Mixed restrictive-obstructive ventilatory defect.
D.Pseudonormalization of lung volumes secondary to chest wall restriction.
Explanation: Pulmonary hyperinflation is defined as an increase in Total Lung Capacity above normal (TLC > 120% of predicted), while air trapping is defined as an increase in Residual Volume (RV > 120% of predicted) and an elevated RV/TLC ratio (> upper limit of normal, typically > 35-40%). When both TLC and RV are elevated, both hyperinflation and air trapping are present.
6A 28-year-old woman presents with severe progressive dyspnea and orthopnea. Pulmonary function testing reveals: FVC = 52% of predicted, FEV1 = 54% of predicted, FEV1/FVC = 0.84, TLC = 60% of predicted, and DLCO = 95% of predicted (DLCO/VA or KCO = 125% of predicted). Which of the following etiologies is most consistent with this physiological pattern?
A.Diaphragmatic weakness secondary to amyotrophic lateral sclerosis or myasthenia gravis.
B.Idiopathic pulmonary fibrosis with severe parenchymal destruction.
C.Nonspecific interstitial pneumonia (NSIP) associated with polymyositis.
D.Chronic hypersensitivity pneumonitis with extensive subpleural fibrosis.
Explanation: Extraparenchymal restrictive disorders (e.g., neuromuscular weakness, diaphragm paralysis, severe kyphoscoliosis) cause reduced lung volumes (low FVC and TLC) while preserving alveolar-capillary membrane integrity. Consequently, the absolute diffusing capacity (DLCO) remains relatively normal and the carbon monoxide transfer coefficient (KCO = DLCO/VA) is characteristically elevated due to preserved capillary blood volume in underexpanded alveoli.
7A 34-year-old man with anti-GBM (Goodpasture) disease develops hemoptysis and acute bilateral alveolar infiltrates. Diffusing capacity of the lung for carbon monoxide (DLCO) is measured at 145% of predicted, and the transfer coefficient (KCO) is 160% of predicted. What pathophysiological mechanism explains this supranormal diffusing capacity?
A.Binding of inhaled carbon monoxide by intra-alveolar erythrocytes and free hemoglobin.
B.Increased pulmonary capillary transit time resulting from reactive precapillary vasoconstriction.
C.Enhanced ventilation-perfusion matching secondary to diffuse recruitment of non-perfused apices.
D.Accelerated transalveolar gas diffusion driven by acute alveolar epithelial thinning.
Explanation: In diffuse alveolar hemorrhage (DAH), extravasated red blood cells and free hemoglobin inside the alveolar spaces actively bind inhaled carbon monoxide during the single-breath measurement. This rapid extra-vascular uptake produces an artificially elevated diffusing capacity (DLCO > 100-120% of predicted) and an elevated KCO.
8An arterial blood gas (ABG) sample obtained on room air (FiO2 0.21) at sea level from a 58-year-old morbidly obese patient (BMI 44 kg/m²) shows: pH = 7.33, PaCO2 = 60 mmHg, PaO2 = 62 mmHg, and HCO3- = 31 mEq/L. Assuming a respiratory quotient (R) of 0.8 and barometric pressure of 760 mmHg (water vapor pressure 47 mmHg), what is the calculated Alveolar-arterial oxygen gradient [P(A-a)O2] and its physiological interpretation?
A.P(A-a)O2 is approximately 13 mmHg (normal), indicating pure alveolar hypoventilation without intrinsic parenchymal lung disease.
B.P(A-a)O2 is approximately 38 mmHg (elevated), indicating significant intrapulmonary right-to-left shunting.
C.P(A-a)O2 is approximately 4 mmHg (subnormal), indicating compensatory hyperdiffusion across the alveolar membrane.
D.P(A-a)O2 is approximately 55 mmHg (severely elevated), indicating extensive alveolar-capillary block.
Explanation: PAO2 = FiO2*(Pbar - PH2O) - (PaCO2 / R) = 0.21*(760 - 47) - (60 / 0.8) = 149.7 - 75 = 74.7 mmHg. The P(A-a)O2 is PAO2 - PaO2 = 74.7 - 62 = 12.7 mmHg. For a 58-year-old, a gradient < 15-20 mmHg is normal. A normal P(A-a)O2 in the presence of hypoxemia and hypercapnia confirms that hypoxemia is entirely driven by pure alveolar hypoventilation (typical of Obesity Hypoventilation Syndrome).
9A 60-year-old man with acute severe dyspnea is placed on 100% inspired oxygen (FiO2 1.0) via a non-rebreather mask. An arterial blood gas reveals PaO2 = 72 mmHg and PaCO2 = 34 mmHg. What pathophysiological mechanism of hypoxemia is confirmed by this failure of supplemental oxygen to substantially correct the PaO2?
A.Anatomical or physiological right-to-left intrapulmonary shunt.
B.Low ventilation-perfusion (V/Q) ratio mismatch responsive to high alveolar PO2.
C.Pure diffusion limitation across the blood-gas barrier.
D.Generalized alveolar hypoventilation secondary to central respiratory depression.
Explanation: True right-to-left intrapulmonary or intracardiac shunting occurs when deoxygenated mixed venous blood bypasses ventilated alveoli completely (e.g., dense alveolar consolidation in severe ARDS, pulmonary arteriovenous malformations, or Eisenmenger syndrome). Administering 100% FiO2 cannot oxygenate blood passing through non-ventilated units, failing to raise PaO2 above ~500 mmHg (unlike V/Q mismatch or diffusion defects, which correct with high FiO2).
10A 42-year-old woman with unexplained exertional dyspnea undergoes incremental cardiopulmonary exercise testing (CPET). The study demonstrates: markedly reduced peak oxygen uptake (peak VO2 = 48% of predicted), early anaerobic threshold, elevated ventilatory equivalent for carbon dioxide (VE/VCO2 slope = 46; normal < 30), exercise-induced oxygen desaturation, and a preserved breathing reserve (BR = 45%). What clinical pattern does this CPET profile indicate?
A.Pulmonary vascular impairment (such as pulmonary arterial hypertension or chronic thromboembolic disease).
B.Severe ventilatory mechanical limitation due to advanced chronic obstructive pulmonary disease.
C.Severe psychogenic hyperventilation without physiological circulatory abnormality.
D.Deconditioning syndrome with normal exercise ventilatory efficiency.
Explanation: In pulmonary vascular disease, high alveolar dead space causes severe ventilatory inefficiency, evidenced by an elevated VE/VCO2 slope (> 35-40), low peak VO2, early anaerobic threshold, and exertional desaturation, while mechanical ventilatory capacity remains preserved (breathing reserve > 30-40%). In contrast, ventilatory limitation would exhaust breathing reserve (BR < 15-20%).

About the Pneumologia SBPT Exam

The Título de Especialista em Pneumologia e Tisiologia is the official medical board certification for pulmonologists and phthisiologists in Brazil, awarded by the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT) in partnership with the Associação Médica Brasileira (AMB) and registered with the Conselho Federal de Medicina (CFM). The examination assesses comprehensive clinical competence across all areas of modern respiratory medicine, including pulmonary function tests (spirometry, plethysmography, DLCO), obstructive airway diseases (asthma, COPD, bronchiectasis), interstitial lung diseases (IPF, sarcoidosis, hypersensitivity pneumonitis), mycobacteriology and tuberculosis (PNCT Brasil), pulmonary vascular conditions (PE, PAH), thoracic oncology (pulmonary nodules, lung cancer, EBUS), pleural diseases, sleep-disordered breathing (OSA), and critical care mechanical ventilation. Obtaining the specialist title allows physicians to register their Registro de Qualificação de Especialista (RQE) with their respective Regional Medical Council (CRM).

Assessment

Single-day examination administered by the Comissão de Título de Especialista of the SBPT in conjunction with AMB. Prova Teórica: Multiple-choice questions evaluating respiratory physiology, pathology, pharmacology, and clinical guidelines. Prova Teórico-Prática: Clinical vignette questions evaluating chest radiography, thoracic HRCT, spirometric and plethysmographic graphs, polysomnography, and bronchoscopy. Análise Curricular: Scoring of medical residency, fellowship, clinical experience, and scientific publications.

Time Limit

4 to 5 hours of total examination time on a single day

Passing Score

Final score of at least 60% (6.0 out of 10.0) combined across theoretical and practical stages

Exam Fee

Set each year in the official Edital; consult the current edital for the registration fee and any member discount. (Sociedade Brasileira de Pneumologia e Tisiologia (SBPT) — Associação Médica Brasileira (AMB))

Pneumologia SBPT Exam Content Outline

15%

Fisiologia e Testes de Função Pulmonar

Spirometry (FEV1, FVC, FEV1/FVC, bronchodilator responsiveness, LLN vs fixed cutoffs), body plethysmography (TLC, RV, FRC, RV/TLC), diffusing capacity (DLCO, VA, KCO), arterial blood gases (A-a gradient, shunt vs dead space), cardiopulmonary exercise testing (CPET), and 6-minute walk test (6MWT).

20%

Doenças Obstrutivas das Vias Aéreas (Asma, DPOC e Bronquiectasias)

Asthma pathophysiology, GINA/SBPT management steps, MART/SMART strategy, severe asthma phenotyping (T2-high vs T2-low), monoclonal antibody biologicals (anti-IgE, anti-IL5, anti-IL5R, anti-IL4R, anti-TSLP); COPD GOLD/SBPT classification (ABE), LABA/LAMA/ICS indications, non-pharmacologic interventions (LTOT, LVRS, endobronchial valves, pulmonary rehab); bronchiectasis etiology, non-CF and CF management, macrolide maintenance; and Alpha-1 antitrypsin deficiency.

15%

Doenças Pulmonares Intersticiais e Granulomatosas

Idiopathic Pulmonary Fibrosis (IPF, HRCT UIP pattern, antifibrotics pirfenidone and nintedanib); Hypersensitivity Pneumonitis (acute and fibrotic HP, BAL lymphocytosis); Sarcoidosis (Scadding staging, Lofgren syndrome, immunosuppression); Connective Tissue Disease-associated ILD (systemic sclerosis, rheumatoid arthritis, antisynthetase syndrome); Cryptogenic Organizing Pneumonia (COP); and alveolar proteinosis.

20%

Tisiologia, Micobactérias e Infecções Respiratórias

Tuberculosis (PNCT Ministério da Saúde guidelines, GeneXpert MTB/RIF, smear and culture, 2RHZE/4RH standard regimen, hepatotoxicity management, drug-resistant TB, latent TB infection TST/IGRA, 3HP/4R/9H regimens); Nontuberculous Mycobacteria (MAC, M. kansasii, M. abscessus); Community-Acquired Pneumonia (CURB-65, PSI, inpatient/outpatient therapy); Hospital-Acquired/Ventilator-Associated Pneumonia; Endemic Mycoses in Brazil (Paracoccidioidomycosis, Histoplasmosis, Aspergillosis ABPA/invasive); and PJP.

10%

Circulação Pulmonar (TEP, Hipertensão Pulmonar e Vasculites)

Acute Pulmonary Thromboembolism (PESI/sPESI risk stratification, systemic thrombolysis in high-risk PE, anticoagulation with DOACs/LMWH, CTEPH diagnosis and management); Pulmonary Arterial Hypertension (PAH hemodynamic definition: mean PAP > 20 mmHg, PAWP ≤ 15 mmHg, PVR ≥ 2 WU; vasoreactivity testing, ERA, PDE5i, riociguat, prostacyclin analogs); and Pulmonary Vasculitides (GPA, EGPA).

10%

Pleura, Mediastino e Oncologia Torácica

Pleural effusion (Light's criteria for transudate vs exudate, tuberculous pleurisy ADA > 40 U/L, complicated parapneumonic effusion and empyema drainage/fibrinolytics); Pneumothorax; Malignant Pleural Mesothelioma; Mediastinal masses; Solitary Pulmonary Nodule (Fleischner Society 2017 criteria); Lung cancer screening (low-dose CT); TNM 8th/9th edition staging; and diagnostic bronchoscopy/EBUS-TBNA.

10%

Medicina do Sono e Terapia Intensiva Respiratória

Obstructive Sleep Apnea (AHI classification, CPAP indications and titration); Obesity Hypoventilation Syndrome; Acute Respiratory Distress Syndrome (ARDS Berlin definition, severity tiers); Protective mechanical ventilation (tidal volume 4-8 mL/kg PBW, plateau pressure ≤ 30 cmH2O, driving pressure ≤ 14 cmH2O, prone positioning for PaO2/FiO2 < 150); and non-invasive ventilation (NIV) indications and contraindications.

How to Pass the Pneumologia SBPT Exam

What You Need to Know

  • Passing score: Final score of at least 60% (6.0 out of 10.0) combined across theoretical and practical stages
  • Assessment: Single-day examination administered by the Comissão de Título de Especialista of the SBPT in conjunction with AMB. Prova Teórica: Multiple-choice questions evaluating respiratory physiology, pathology, pharmacology, and clinical guidelines. Prova Teórico-Prática: Clinical vignette questions evaluating chest radiography, thoracic HRCT, spirometric and plethysmographic graphs, polysomnography, and bronchoscopy. Análise Curricular: Scoring of medical residency, fellowship, clinical experience, and scientific publications.
  • Time limit: 4 to 5 hours of total examination time on a single day
  • Exam fee: Set each year in the official Edital; consult the current edital for the registration fee and any member discount.

Keys to Passing

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Pneumologia SBPT Study Tips from Top Performers

1Master Pulmonary Function Test Interpretation: Know the exact criteria for spirometric quality and reproducibility, the definition of airflow obstruction using the lower limit of normal (LLN) or fixed FEV1/FVC < 0.70, significant bronchodilator response (increase of ≥200 mL AND ≥12% in FEV1 or FVC), lung volumes by plethysmography (restriction defined by TLC < LLN or < 80%, air trapping by RV/TLC > upper limit, hyperinflation by TLC > 120%), and diffusing capacity (DLCO) corrected for hemoglobin.
2Internalize Brazilian National Tuberculosis Program (PNCT) Protocols: Master the standard 2RHZE/4RH fixed-dose combination regimen (rifampicin, isoniazid, pyrazinamide, ethambutol), indications and interpretation of rapid molecular testing (GeneXpert MTB/RIF and Ultra), management of hepatotoxicity (stopping therapy when transaminases reach ≥5x ULN asymptomatic or ≥3x ULN with symptoms, sequential rechallenge order: Rifampicin -> Isoniazid -> Pyrazinamide), latent TB infection regimens (3HP, 4R, 9H), and TST/IGRA cutoffs.
3Understand Asthma & COPD Management Algorithms: Master GINA/SBPT Track 1 (MART with low-dose ICS-formoterol as both maintenance and reliever) versus Track 2, severe asthma biologic selection based on biomarkers (anti-IgE omalizumab for allergic asthma with elevated IgE; anti-IL5/IL5R mepolizumab/benralizumab for eosinophilic asthma; anti-IL4R dupilumab for eosinophilic/elevated FeNO; anti-TSLP tezepelumab for broad severe asthma). For COPD, master GOLD ABE grouping, LABA/LAMA first-line, and blood eosinophil thresholds (≥300 cells/µL) for adding inhaled corticosteroids.
4Recognize Interstitial Lung Disease (ILD) Patterns on HRCT: Accurately distinguish the definitive UIP pattern (subpleural, basal predominance, reticular abnormality, honeycombing with or without traction bronchiectasis, absence of inconsistent features) from NSIP, hypersensitivity pneumonitis (three-density sign / headcheese sign, mosaic attenuation, air trapping on expiratory CT), cryptogenic organizing pneumonia (peribronchovascular consolidations, reverse halo / atoll sign), and sarcoidosis (perilymphatic nodules, symmetric hilar lymphadenopathy).
5Correlate Pulmonary Vascular & Pleural Diseases: Internalize pulmonary arterial hypertension hemodynamic criteria (mean PAP > 20 mmHg, PAWP ≤ 15 mmHg, PVR ≥ 2 Wood Units), acute vasoreactivity testing with inhaled nitric oxide, and pulmonary embolism risk stratification (PESI score, RV strain, troponin/BNP, systemic thrombolysis for high-risk massive PE). For pleural effusions, master Light's criteria and complicated parapneumonic effusion drainage thresholds (pH < 7.20, glucose < 40-60 mg/dL, positive Gram/culture).
6Apply Evidence-Based Critical Care & ARDS Protocols: Memorize the Berlin definition of ARDS (mild P/F 200-300, moderate 100-200, severe ≤ 100 on PEEP ≥ 5), low tidal volume ventilation (4-8 mL/kg of predicted body weight), plateau pressure goal ≤ 30 cmH2O, driving pressure goal ≤ 14-15 cmH2O, and early prone positioning (≥16 hours/day) for severe ARDS with PaO2/FiO2 < 150.

Frequently Asked Questions

What is the Título de Especialista em Pneumologia e Tisiologia and why is it important in Brazil?

The Título de Especialista em Pneumologia e Tisiologia is the official specialist board certification awarded jointly by the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT) and the Associação Médica Brasileira (AMB). Earning this title enables physicians to register their specialized qualification (Registro de Qualificação de Especialista - RQE) in Pulmonology with the Regional Medical Councils (CRMs) and the Federal Council of Medicine (CFM), fulfilling the legal requirement to practice and advertise as a pulmonologist in Brazil.

What are the eligibility requirements to sit for the SBPT specialist examination?

Candidates must hold an active medical license with a Brazilian CRM and satisfy one of the qualifying pathways: (1) Completion of an accredited Medical Residency Program (CNRM/MEC) in Pneumologia; (2) Completion of an SBPT-recognized specialization training program; or (3) Proven clinical practice in Pulmonology for at least double the duration of official residency (typically 6 to 8 years), validated through official institutional documentation and achieving the required minimum curricular score stipulated in the annual Edital.

How is the official SBPT specialty examination structured?

The examination is conducted in two main parts: (1) Prova Teórica (Theoretical Exam), evaluating pathophysiology, pharmacology, evidence-based pulmonology, and national/international guidelines (SBPT, PNCT, GINA, GOLD); and (2) Prova Teórico-Prática (Theoretical-Practical Exam), presenting clinical case vignettes accompanied by chest radiography, high-resolution computed tomography (HRCT), spirometry and plethysmography loops, diffusing capacity reports, sleep studies, and bronchoscopic images. An Análise Curricular evaluates academic training, residency, and scientific output.

What are the key clinical guidelines tested on the SBPT exam?

The exam heavily emphasizes the Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia published in the Jornal Brasileiro de Pneumologia (JBP), including guidelines on Pulmonary Function Tests, Asthma, COPD, Interstitial Lung Diseases, Pulmonary Hypertension, Mechanical Ventilation, and Endemic Mycoses. In addition, the Brazilian Ministry of Health's Manual de Recomendações para o Controle da Tuberculose no Brasil (PNCT) is fundamental for the phthisiology (tisiologia) portion of the syllabus.

Why is this OpenExamPrep practice bank presented in English?

This practice bank is an English-language MCQ study adaptation designed to support international pulmonology fellows, Brazilian candidates preparing with international literature, and clinicians worldwide. The real SBPT examination is conducted in Portuguese. All official Brazilian terminology (e.g., PNCT tuberculosis regimens, SBPT diagnostic criteria, and JBP consensus standards) is maintained inline throughout the questions and explanations.